One pill, once a day
If other treatments like 5-ASAs† or steroids aren’t working well enough* for you, ask your doctor about oral VELSIPITY.
†5-ASAs are 5-aminosalicylic acid derivatives.
*In VELSIPITY studies, people with moderately to severely active ulcerative colitis had an inadequate response, loss of response, or intolerance to one or more of the following treatment options: oral aminosalicylates, corticosteroids, thiopurines, Janus kinase (JAK) inhibitors, or biologics prior to enrollment.
Learn more about VELSIPITY


It may cause serious side effects including infections that can be fatal, slow heart rate,…
1-800-350-3080 | Visit VELSIPITY.com for cost info [Pfizer logo]
PP-V1A-USA-1028 ©2025 Pfizer, Inc.
All rights reserved. April 2025.
More people on VELSIPITY achieved clinical remission* in just 3 months versus those taking the placebo.
VELSIPITY is the newest medication of its class for moderate to severe UC in adults.
The safety of VELSIPITY was studied in a clinical program with 577 participants across 3 placebo-controlled studies.
Explore the details of VELSIPITY.
Select one from the list to learn more.
VELSIPITY could be a chance to help manage moderate to severe UC.
Want to learn more about VELSIPITY?